Akebia Therapeutics Inc.

AKBA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.97

+$0.03 (+3.36%)

Sep 22, 2026, 12:07 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-5.35M	-69.41M	-51.93M	-92.56M	-282.02M	-383.46M
Depreciation & Amortization	1.27M	37.5M	41.85M	37.7M	37.97M	33.59M
Stock-Based Compensation	11.28M	7.78M	9.32M	17.85M	22.74M	24.46M
Other Working Capital	50.66M	-13.96M	-13.94M	-34.42M	-44.9M	-35.52M
Other Non-Cash Items	44.31M	23.15M	-1.9M	-34.7M	73.97M	24.61M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	204.08M
Change in Working Capital	16.47M	-39.68M	-20.73M	-1.44M	-105.61M	-13.67M
Operating Cash Flow	67.99M	-40.66M	-23.38M	-73.15M	-252.97M	-110.39M
Capital Expenditures	-291K	-33K	n/a	-114K	-59K	-317K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	39.69M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	-99.93M
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	40M	60.25M
Other Investing Acitivies	-7.93M	n/a	n/a	n/a	n/a	-39.69M
Investing Cash Flow	-7.93M	-33K	n/a	-114K	39.94M	-40M
Debt Repayment	4.63M	7.9M	-32M	-33M	n/a	19.98M
Common Stock Repurchased	n/a	-1.27M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-63K	385K	1K	40.07M	44.78M	1.23M
Financial Cash Flow	72.93M	49.66M	-25.21M	14.6M	133.73M	231.72M
Net Cash Flow	132.99M	8.97M	-48.59M	-58.67M	-79.29M	81.33M
Free Cash Flow	67.99M	-40.69M	-23.38M	-73.27M	-253.02M	-110.71M
Adj. Free Cash Flow	56.71M	-48.47M	-32.7M	-91.12M	-275.76M	-135.17M
Maintenance CapEx	n/a	-33K	n/a	n/a	-59K	-317K
Growth CapEx	-291K	n/a	n/a	-114K	n/a	n/a
Owner Earnings	67.99M	-40.69M	-23.38M	-73.15M	-253.02M	-110.71M